Clinical Trials in Seattle

Showing 2901-2920 of 8,049 trials

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

This is a multi-center, open-label Phase 0 Master Protocol designed to study the localized pharmacodynamics (PD) of anti-cancer therapies within the tumor microenvironment (TME) when administered intratumorally in microdose quantities via the CIVO device in patients with surface accessible solid tumors for which there is a scheduled surgical intervention. CIVO stands for Comparative In Vivo Oncology. Multiple substudies will include specified investigational agents and combinations to be evaluated.

Solid Tumor

Presage Biosciences15 participantsStarted Jul 2021

Sacramento, California, United States • Atlanta, Georgia, United States • Shreveport, Louisiana, United States +9 more locations

COMPLETEDPhase 3< 1 mile

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

NCT04729621

The purpose of this study is to demonstrate similar efficacy and safety between TVB-009 and Prolia® (denosumab)

Osteoporosis, Postmenopausal

Teva Pharmaceuticals USA332 participantsStarted Mar 2021

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +75 more locations

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Find Trials by Condition in Seattle

Letrozole for Lymphangioleiomyomatosis

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Cancer Stem Cell High-Throughput Drug Screening Study

A Pilot RCT of the PRISM Intervention for AYAs With Cancer

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

A Study of MRx-4DP0004 in Asthma